Pacira | PCRX - Net Income


Pacira reported $5.43M in Net Income for its fiscal quarter ending in September of 2025.





Net Income Change Date
Astellas Pharma JPY 100.38B 21.17B Dec/2025
Bristol-Myers Squibb USD 1.09B 1.11B Dec/2025
Ironwood Pharmaceuticals USD 3.19M 457K Dec/2024
J&J USD 5.12B 36M Dec/2025
Ligand Pharmaceuticals USD 117.27M 112.43M Sep/2025
Novo Nordisk DKK 26.89B 388M Dec/2025
Pacira USD 5.43M 10.28M Sep/2025
Perrigo USD 7.5M 15.9M Sep/2025
Pfizer USD -1.65B 5.19B Dec/2025
Supernus Pharmaceuticals USD -45.12M 67.62M Sep/2025
Teva Pharmaceutical Industries USD 480M 47M Dec/2025
Xeris Pharmaceuticals USD 621K 2.55M Sep/2025
Zoetis USD 721M 3M Sep/2025